Triacetylfusarinine C: A urine biomarker for diagnosis of invasive aspergillosis - 01/02/19
Highlights |
• | Diagnosis of invasive aspergillosis (IA) is unsatisfying with current methods. |
• | New method for quantification of an Aspergilus siderophore (TAFC) was established. |
• | TAFC determination in urine yielded promising results for diagnosing IA. |
• | Detection in urine offers the advantage of non-invasive sampling. |
Summary |
Objectives |
Early diagnosis of invasive aspergillosis (IA) remains challenging, with available diagnostics being limited by inadequate sensitivities and specificities. Triacetylfusarinine C, a fungal siderophore that has been shown to accumulate in urine in animal models, is a potential new biomarker for diagnosis of IA.
Methods |
We developed a method allowing absolute and matrix-independent mass spectrometric quantification of TAFC. Urine TAFC, normalized to creatinine, was determined in 44 samples from 24 patients with underlying hematologic malignancies and probable, possible or no IA according to current EORTC/MSG criteria and compared to other established biomarkers measured in urine and same-day blood samples.
Results |
TAFC/creatinine sensitivity, specificity, positive and negative likelihood ratio for probable versus no IA (cut-off ≥ 3) were 0.86, 0.88, 6.86, 0.16 per patient.
Conclusion |
For the first time, we provide proof for the occurrence of TAFC in human urine. TAFC/creatinine index determination in urine showed promising results for diagnosis of IA offering the advantages of non-invasive sampling. Sensitivity and specificity were similar as reported for GM determination in serum and bronchoalveolar lavage, the gold standard mycological criterion for IA diagnosis.
Le texte complet de cet article est disponible en PDF.Graphical abstract |
Keywords : Aspergillosis, Biomarker, Diagnosis, Siderophore, Urine
Abbreviations : Amb, BALF, BGE, Casp, CE, crea, EORTC/MSG, ESI, Flu, GM, IA, ICU, IQR, LC, ms, ODI, pIA, Pos, Tx, Vor iv
Plan
Vol 78 - N° 2
P. 150-157 - février 2019 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?